What is RetinaLogik?
RetinaLogik is a developer of vision screening technology platforms designed to prevent vision loss by making smarter vision screening accessible to everyone. The company's eye exam technology platform assists users in checking their vision on intelligent and portable devices, enabling customers to achieve clear vision at affordable prices and detect conditions early. This focus on accessible and early detection technology positions RetinaLogik as a key player in the health-tech sector, particularly in preventative eye care solutions.
How much funding has RetinaLogik raised?
RetinaLogik has raised a total of $1.7M across 2 funding rounds:
Other Financing Round
$577K
Debt
$1.1M
Other Financing Round (2024): $577K with participation from Halo Behavioral Health
Debt (2025): $1.1M led by Health Canada | Santé Canada
Key Investors in RetinaLogik
Health Canada | Santé Canada
Health Canada | Santé Canada is the Federal department responsible for helping Canadians maintain and improve their health. Their involvement suggests a strategic alignment with public health initiatives and the accessibility of healthcare technologies.
Halo Behavioral Health
Halo Behavioral Health offers comprehensive, evidence-based behavioral support services. Their participation in RetinaLogik's funding round may indicate an interest in the intersection of behavioral health and accessible diagnostic technologies.
What's next for RetinaLogik?
The substantial enterprise-level funding and recent strategic investment indicate a strong market validation for RetinaLogik's vision screening technology. This capital infusion is likely to fuel further research and development, enhance product scalability, and expand market reach. The company is poised to leverage this backing to solidify its position in the preventative eye care market, potentially exploring new partnerships and technological advancements to further its mission of making vision screening universally accessible and affordable.
See full RetinaLogik company page
